Akiyoshi Mochizuki - Concepedia

Author

Akiyoshi Mochizuki

Daiichi-Sankyo (Japan)

Also Known As

A. MOCHIZUKI, Akiyoshi MOCHIZUKI, Akiyoshi Mochizuki

Publications

265

Citations

H-Index

Concepts

All Affiliations

Daiichi-Sankyo (Japan)Daiichi Sankyo (Germany)Daiichi University of Pharmacy

About

Akiyoshi Mochizuki is an author at Daiichi-Sankyo (Japan) specializing in natural sciences, pharmacology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Natural Sciences	8	8	219
2	Medicine	7	7	206
3	Biochemistry	4	4	122
4	Engineering	1	1	13
5	Applied Physics	1	1	13

Akiyoshi Mochizuki

Publications

219

Citations

H-Index

Page 1

	Year	Citations
Design, synthesis, and SAR of cis-1,2-diaminocyclohexane derivatives as potent factor Xa inhibitors. Part II: Exploration of 6–6 fused rings as alternative S1 moieties Kenji Yoshikawa, Shozo Kobayashi, Yumi Nakamoto, Bioorganic & Medicinal Chemistry Medicinal ChemistryNatural SciencesDrug DiscoveryDiversity-oriented SynthesisMedicine	2009	42
Design, synthesis, and biological activity of novel factor Xa inhibitors: Improving metabolic stability by S1 and S4 ligand modification Satoshi Komoriya, Shozo Kobayashi, Ken Osanai, Bioorganic & Medicinal Chemistry Biological ActivityMedicinal ChemistryMetabolic StabilityBiochemistryNatural Sciences	2005	42
Design, synthesis, and biological activity of piperidine diamine derivatives as factor Xa inhibitor Akiyoshi Mochizuki, Yumi Nakamoto, Hiroyuki Naito, Bioorganic & Medicinal Chemistry Letters Biological ActivityCombinatorial ChemistryMedicinal ChemistryBiochemistryPiperidine Diamine Derivatives	2007	38
Design, synthesis, and SAR of cis-1,2-diaminocyclohexane derivatives as potent factor Xa inhibitors. Part I: Exploration of 5–6 fused rings as alternative S1 moieties Kenji Yoshikawa, Aki Yokomizo, Hiroyuki Naito, Bioorganic & Medicinal Chemistry Medicinal ChemistryCis-1,2-diaminocyclohexane DerivativesHeterocyclicNatural SciencesMedicine	2009	31
Design, synthesis, and biological activity of non-basic compounds as factor Xa inhibitors: SAR study of S1 and aryl binding sites Satoshi Komoriya, Noriyasu Haginoya, Shozo Kobayashi, Bioorganic & Medicinal Chemistry Medicinal ChemistryBiochemistryMedicineNatural SciencesRational Drug Design	2005	30
Microwave spectrum, barrier to internal rotation, and dipole moment of 1,2,3-pentatriene Teruhiko Ogata, Akiyoshi Mochizuki, Eiichi Yamashita The Journal of Chemical Physics EngineeringInternal RotationMagnetic ResonanceDipole MomentChemistry	1987	13
Lead optimization of 5-amino-6-(2,2-dimethyl-5-oxo-4-phenylpiperazin-1-yl)-4-hydroxyhexanamides to reduce a cardiac safety issue: Discovery of DS-8108b, an orally active renin inhibitor Yuji Nakamura, Teppei Fujimoto, Yasuyuki Ogawa, Bioorganic & Medicinal Chemistry Medicinal ChemistryCardiac Safety IssueBiochemistryMedicineNatural Sciences	2013	12
Design, synthesis and SAR of novel ethylenediamine and phenylenediamine derivatives as factor Xa inhibitors Kenji Yoshikawa, Toshiharu Yoshino, Yoshihiro Yokomizo, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryPharmaceutical ScienceMedicineNatural SciencesPhenylenediamine Derivatives	2011	11

Page 1